A Real-world Data and Sample Compendium of Frail and/or Multiply Treated Large B-cell Lymphoma
N/A
LBCL is a cancer of the lymphatic system where B-cells (a type of white blo...
Status
Recruiting
Location
The Clatterbridge Cancer Centre NHS Foundation Trust
Start Date
2024-10-30
Trial ID
NCT07335120
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
PHASE2
Researchers are looking for ways to treat germinal center B-cell-like diffu...
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
PHASE3
This Phase III, randomized, double-blind, placebo-controlled study will com...